by Mark Curtis | Nov 27, 2013
. Welcome to the regenerative medicine deal review for the month of November. Cytori Therapeutics and Lorem Vascular have teamed up to catalyze the commercialization of Cytori cell therapies using its proprietary Celution® System in Asia. There was also a notable deal...
by Mark Curtis | Nov 19, 2013
. Welcome to October’s Update from the Clinic. Interesting developments this past month included the release of Phase 1/2a data from Living Cell Technologies that provides a first look at the safety and efficacy of its DIABECELL® product. We also saw an approval for...
by Stacey Johnson | Nov 15, 2013
. Sometimes too much choice can be a bad thing. It paralyzes you. I was flummoxed by the many options available to me in selecting what to feature on Right Turn this week. Then it struck me: I have the perfect item right under my nose (so to speak). CCRM just launched...
by David Brindley | Oct 25, 2013
. Nestled in the bosom of the Canadian Rockies, the global regenerative medicine community is assembled. Coaches laden with young investigators sporting impractically packed posters and drawn, jet lagged expressions are arriving in a steady procession. The usually...
by David Brindley | Oct 24, 2013
. 9am, Day 1: IBC Cell Therapy Bioprocessing Conference (Bethesda, MD, USA): Attempting to sharpen tie, and my welcome isolation is interrupted by a lady entering the elevator and fighting for mirror space. Cue small talk: “That’s a nice tie.” “Erm, thank you.” “And...
by David Brindley | Oct 23, 2013
. The Cell Therapy Industry’s equivalent of ‘Wimbledon Fortnight,’ is upon us: ARM’s successfully delivered Meeting on the Mesa (La Jolla, CA) has served as a tantalizing hors d’oeuvre to IBC’s Cell Therapy Bioprocessing Conference (Bethesda, MD) and CCRM’s and...
Comments